Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|22|2594-2602

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.22, 2009-08, pp. : 2594-2602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Progress in the Genetic Research of Schizophrenia: Relevance for Drug Discovery?

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1614-1621

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Schizophrenia

By  

Current Neuropharmacology, Vol. 1, Iss. 4, 2003-12 ,pp. : 351-370

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 3, 2002-06 ,pp. : 261-281

Bentham Science Publishers

Access to resources Recommend Favorite

Can functional magnetic resonance imaging improve success rates in central nervous system drug discovery?

By Borsook David   Hargreaves Richard J   Becerra Lino  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 6, 2011-06 ,pp. : 597-617

Informa Healthcare

Access to resources Recommend Favorite